HIGHLIGHTS
- who: Juntao Yuan and collaborators from the College of Life Science, University of Chinese Academy of Sciences, Beijing, China have published the research: Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice, in the Journal: Antioxidants 2022, 1584 of /2022/
- what: The authors used Gcn2-/- mice, AAV8-shGcn2, and the GCN2-specific inhibitor GCN2iB to investigate the effect of GCN2 on glucolipid metabolism in T2D mice. This study has two major findings. This study showed that inhibition of GCN2 in T2D mice by gene deletion or a specific . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.